Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetics and oncogenes in leukemia

D E Hogge1

  • 1Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, Canada.

Current Opinion in Oncology
|January 1, 1994
PubMed
Summary

Chromosomal abnormalities in leukemia cells offer diagnostic and prognostic insights. Molecular analysis of these genetic changes aids in understanding cancer development and improving clinical assays.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study.

Bone marrow transplantation·2016
Same author

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.

Bone marrow transplantation·2009
Same author

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results.

Bone marrow transplantation·2008
Same author

Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.

Bone marrow transplantation·2008
Same author

Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia.

Annals of oncology : official journal of the European Society for Medical Oncology·2007
Same author

Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes.

Annals of oncology : official journal of the European Society for Medical Oncology·2006

Area of Science:

  • Hematology
  • Oncology
  • Human Genetics

Background:

  • Chromosomal abnormalities in leukemia cells are crucial for diagnosis and prognosis.
  • Gene cloning from translocation breakpoints reveals insights into cell growth, differentiation, and cancer pathogenesis.

Purpose of the Study:

  • To review recent analyses associating specific karyotypic changes with leukemia characteristics and treatment outcomes.
  • To summarize progress in molecular analysis of genetic abnormalities in leukemia, focusing on chromosomal rearrangements.
  • To highlight the development of clinical assays based on molecular findings.

Main Methods:

  • Review of recent scientific literature on chromosomal abnormalities in leukemia.
  • Analysis of studies linking karyotypic changes to disease characteristics and treatment outcomes.
  • Examination of molecular analyses of genetic abnormalities, particularly chromosomal rearrangements.

Main Results:

  • Specific karyotypic changes correlate with disease characteristics and treatment outcomes in leukemia patients.
  • Significant advancements have been made in the molecular understanding of genetic abnormalities in leukemia.
  • Molecular findings are being translated into clinical diagnostic tools.

Conclusions:

  • Understanding chromosomal abnormalities in leukemia is vital for diagnosis, prognosis, and treatment.
  • Molecular analysis of genetic changes, especially chromosomal rearrangements, deepens insights into leukemia pathogenesis.
  • Developed molecular assays like polymerase chain reaction and fluorescent in situ hybridization improve clinical management of leukemia.

Related Experiment Videos